Nordic Cochrane Research Center Files Complaint About Scientific Misconduct, Secrecy in HPV Vaccine ProbeNordic Cochrane Center, a Danish research and information center is challenging the European Medicines Agency’s (EMA) 2015 report on human papillomavirus (HPV) vaccines and the EMA’s position that HPV vaccine benefits outweigh the risks. After numerous reports of HPV vaccine-related brain and immune system injuries and deaths, the Danish Health and Medicines Authority asked the EMA to conduct the probe into HPV vaccine safety, but prominent physicians in the country are not convinced about the EMA’s conclusions downplaying the vaccine’s risks. On May 26, 2016, the Nordic Cochrane Center filed an official complaint charging the EMA with “maladministration” and citing flaws throughout the agency’s report. The EMA replied that it has received the complain and will respond after carefully considering all the issues raised by the research group. The Nordic Cochrane Center is an independent research and information center that is part of Cochrane, an international network of individuals and institutions committed to preparing, maintaining, and disseminating systematic reviews of the effects of health care.